Mark Cuban Cost Plus Drug Company partners with pharma company, COPD Foundation
The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Chronic Obstructive Pulmonary | Cuba Health | Information Technology | Pharmaceuticals | Spiriva | Tiotropium